Polfa to buy Russian firm

NewConnect-listed pharmaceutical firm Polfa has signed a letter of intent on the acquisition of Russian manufacturer Biokhimik, the company said in a statement. Polfa plans to buy a majority, controlling stake in the Russian firm. After the takeover is completed, Biokhimik will be renamed Polfa Russia. The factory will be modernized. Polfa plans to implement…

This content is for Silver 6 months, Gold 1 Year and Bronze 2 weeks members only.
Log In Buy Subscription
Pin It